# Protara Therapeutics, Inc.: Form 8-K, filed Jun 8, 2023

- Company: [Protara Therapeutics, Inc.](/companies/tara.md) (CIK 1359931)
- Form: 8-K
- Filed: 2023-06-08
- Accepted by EDGAR: Jun 8, 2023, 16:06 ET
- Period: 2023-06-07
- Accession: 0001213900-23-047460
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1359931/000121390023047460/ea179944-8k_protara.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1359931/000121390023047460/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1359931/000121390023047460/ea179944-8k_protara.htm

Filed Jun 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-047460. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.